Furthermore, despite the existence of other potential markers of low-grade inflammation, we decided to use CRP because this molecule is one of the most frequently used for patients with cardiovascular diseases and presents validated cut-offs to easily assess its potential impact on cardiovascular risk [31,74]. Here, CRP is linked to cardiovascular disorder.